Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CME logo CME
Upturn stock ratingUpturn stock rating
CME logo

CME Group Inc (CME)

Upturn stock ratingUpturn stock rating
$262.3
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/12/2025: CME (3-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Number of Analysts

rating

18 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $282.11

1 Year Target Price $282.11

Analysts Price Target For last 52 week
$282.11 Target price
52w Low $203.31
Current$262.3
52w High $288.09

Analysis of Past Performance

Type Stock
Historic Profit 29.92%
Avg. Invested days 66
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 3.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/12/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 94.53B USD
Price to earnings Ratio 25.39
1Y Target Price 282.11
Price to earnings Ratio 25.39
1Y Target Price 282.11
Volume (30-day avg) 18
Beta 0.44
52 Weeks Range 203.31 - 288.09
Updated Date 09/14/2025
52 Weeks Range 203.31 - 288.09
Updated Date 09/14/2025
Dividends yield (FY) 1.83%
Basic EPS (TTM) 10.33

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 58.59%
Operating Margin (TTM) 66.87%

Management Effectiveness

Return on Assets (TTM) 1.74%
Return on Equity (TTM) 13.61%

Valuation

Trailing PE 25.39
Forward PE 22.52
Enterprise Value 95849221211
Price to Sales(TTM) 14.69
Enterprise Value 95849221211
Price to Sales(TTM) 14.69
Enterprise Value to Revenue 14.87
Enterprise Value to EBITDA 17.92
Shares Outstanding 360376992
Shares Floating 358787300
Shares Outstanding 360376992
Shares Floating 358787300
Percent Insiders 0.44
Percent Institutions 91.64

ai summary icon Upturn AI SWOT

CME Group Inc

stock logo

Company Overview

overview logo History and Background

CME Group Inc. was founded in 1848 as the Chicago Board of Trade (CBOT). It merged with the Chicago Mercantile Exchange (CME) in 2007, creating CME Group. Throughout its history, it has pioneered financial derivatives, including futures and options, becoming a leading global derivatives marketplace.

business area logo Core Business Areas

  • Derivatives Trading: CME Group provides a global platform for trading futures and options across various asset classes, including interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals.
  • Clearing Services: CME Clearing provides clearing and settlement services for CME Group's exchanges and other trading venues, managing risk and ensuring the integrity of transactions.
  • Data Services: CME Group offers market data services, providing real-time and historical data, analytics, and tools to market participants.

leadership logo Leadership and Structure

CME Group is led by a CEO and a board of directors. The organizational structure includes various departments responsible for different business areas, such as trading, clearing, technology, and sales.

Top Products and Market Share

overview logo Key Offerings

  • Interest Rate Products: CME Group is the world's leading interest rate derivatives marketplace. It offers contracts based on U.S. Treasury securities, Eurodollars, and other benchmark rates. They hold a significant portion of the market share and competitors include ICE and Eurex.
  • Market Share (%): 60
  • Equity Index Products: CME Group offers futures and options on major equity indexes such as the S&P 500, Nasdaq 100, and Dow Jones Industrial Average. Competitors include ICE and Eurex.
  • Market Share (%): 45
  • Agricultural Commodities: CME Group offers a wide range of agricultural futures and options contracts, including corn, soybeans, wheat, and livestock. Competitors include ICE.
  • Market Share (%): 80
  • Energy Products: CME Group provides a comprehensive suite of energy derivatives, including crude oil, natural gas, and refined products. Competitors include ICE.
  • Market Share (%): 35

Market Dynamics

industry overview logo Industry Overview

The derivatives industry is characterized by increasing globalization, technological advancements, and regulatory changes. Demand for risk management tools and trading opportunities drives growth.

Positioning

CME Group is a dominant player in the global derivatives market, with a strong brand, extensive product portfolio, and advanced technology infrastructure. Its competitive advantages include network effects, clearing expertise, and regulatory compliance.

Total Addressable Market (TAM)

The global derivatives market is estimated to be worth trillions of dollars. CME Group is well positioned to capture a significant share of this market through its diverse product offerings and global reach.

Upturn SWOT Analysis

Strengths

  • Strong Brand Reputation
  • Global Reach
  • Diverse Product Portfolio
  • Advanced Technology Infrastructure
  • Extensive Clearing Expertise

Weaknesses

  • Dependence on Market Volatility
  • Regulatory Scrutiny
  • Technology Infrastructure Expenses
  • Integration Risk from Acquisitions

Opportunities

  • Expansion into New Markets
  • Development of New Products
  • Strategic Acquisitions
  • Leveraging Technology for Innovation
  • Increasing Demand for Risk Management Tools

Threats

  • Increased Competition
  • Regulatory Changes
  • Economic Downturns
  • Cybersecurity Risks
  • Geopolitical Instability

Competitors and Market Share

competitor logo Key Competitors

  • ICE
  • MKTX
  • NDAQ

Competitive Landscape

CME Group's advantages include its strong brand, global reach, and diverse product portfolio. Its disadvantages include regulatory scrutiny and dependence on market volatility.

Major Acquisitions

NEX Group

  • Year: 2018
  • Acquisition Price (USD millions): 5500
  • Strategic Rationale: Expanded CME Group's presence in fixed income and foreign exchange markets.

Growth Trajectory and Initiatives

Historical Growth: CME Group has experienced steady growth in revenue and earnings over the past decade, driven by increasing trading volumes and strategic acquisitions.

Future Projections: Analysts project continued growth for CME Group, driven by expansion into new markets, development of new products, and increasing demand for risk management solutions. Projected Revenue Growth 2024: 5%.

Recent Initiatives: Recent initiatives include expanding its product offerings in digital assets, investing in technology infrastructure, and pursuing strategic acquisitions.

Summary

CME Group is a strong company with a dominant position in the global derivatives market. Its diverse product portfolio and global reach are working well, driving revenue growth. However, regulatory scrutiny and dependence on market volatility remain key challenges to watch out for. Continued investment in technology and strategic acquisitions will be crucial for future growth.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • CME Group's Investor Relations
  • SEC Filings
  • MarketWatch
  • Yahoo Finance
  • Company Website

Disclaimers:

The data and analysis provided are for informational purposes only and should not be considered financial advice. Market conditions and company performance can change, and past results are not indicative of future performance.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About CME Group Inc

Exchange NASDAQ
Headquaters Chicago, IL, United States
IPO Launch date 2002-12-06
Chairman & CEO Mr. Terrence A. Duffy
Sector Financial Services
Industry Financial Data & Stock Exchanges
Full time employees 3760
Full time employees 3760

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.